Interferon induction held captive in tumor cells by Bridgeman, A, Rehwinkel, J

Deoxyguanosine is a TLR7 agonist by Davenne, T, Bridgeman, A, Rigby, R, Rehwinkel, J

Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice. by Ondondo, B, Abdul-Jawad, S, Bridgeman, A, Hanke, T

Vector delivery-dependant effect of human tissue plasminogen activator signal peptide on vaccine induction of T cells by Hanke, T, Ondondo, B, Abdul-Jawad, S, Roshorm, Y, Bridgeman, A

ELECTRONIC-STRUCTURE OF 20-ELECTRON BIS(CYCLOPENTADIENYL)-METAL OXO COMPOUNDS OF GROUP-6 - INVESTIGATION BY PHOTOELECTRON-SPECTROSCOPY by Bridgeman, A, Davis, L, Dixon, S, Green, J, Wright, I

Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1 by Maelfait, J, Bridgeman, A, Benlahrech, A, Cursi, C, Rehwinkel, J

Dual neonate vaccine platform against HIV-1 and M. tuberculosis. by Hopkins, R, Bridgeman, A, Joseph, J, Gilbert, S, McShane, H, Hanke, T

Sensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis by Maelfait, J, Liverpool, L, Bridgeman, A, Ragan, K, Upton, J, Rehwinkel, J

IL-10 Receptor Blockade Enhances CD4 and CD8 T Cell Responses to a Simian Adenovirus-Vectored HIV-1 Vaccine, ChAdV63.HIVconsv by Clutton, G, Bridgeman, A, Mbewe-Mvula, A, Hancock, G, Hanke, T, Dorrell, L

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine. by Bridgeman, A, Roshorm, Y, Lockett, L, Xu, Z, Hopkins, R, Shaw, J, Both, G, Hanke, T

Potential of a New Subgroup D Adenovirus Vector for Vaccination by Martin, S, Terry, H, Bridgeman, A, Harris, C, Blair, E, Arnberg, N, Hanke, T, Easton, A, Burgert, H

Viruses transfer the antiviral second messenger cGAMP between cells by Bridgeman, A, Maelfait, J, Davenne, T, Partridge, T, Peng, Y, Mayer, A, Dong, T, Kaever, V, Borrow, P, Rehwinkel, J

Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges. by Im, E, Hong, J, Roshorm, Y, Bridgeman, A, Létourneau, S, Liljeström, P, Potash, M, Volsky, D, Mcmichael, A, Hanke, T

Design and pre-clinical evaluation of a universal HIV-1 vaccine. by Létourneau, S, Im, E, Mashishi, T, Brereton, C, Bridgeman, A, Yang, H, Dorrell, L, Dong, T, Korber, B, Mcmichael, A, Hanke, T

Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors. by Hopkins, R, Bridgeman, A, Bourne, C, Mbewe-Mvula, A, Sadoff, J, Both, G, Joseph, J, Fulkerson, J, Hanke, T

Optimizing HIV-1-specific CD8 + T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors by Hopkins, R, Bridgeman, A, Bourne, C, Mbewe-Mvula, A, Sadoff, J, Both, G, Joseph, J, Fulkerson, J, Hanke, T

P17-05. Dealing with HIV-1 diversity by Rosario, M, Borthwick, N, Bridgeman, A, Watkins, D, Colloca, S, Quakkelaar, E, Liljestrom, P, Nicosia, A, Melief, C, Hanke, T

Dealing with HIV-I diversity by Rosario, M, Borthwick, N, Bridgeman, A, Watkins, D, Colloca, S, Quakkelaar, E, Liljestrom, P, Nicosia, A, Melief, C, Hanke, T

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques. by Rosario, M, Fulkerson, J, Soneji, S, Parker, J, Im, E, Borthwick, N, Bridgeman, A, Bourne, C, Joseph, J, Sadoff, J, Hanke, T

Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine. by Knudsen, M, Mbewe-Mvula, A, Rosario, M, Johansson, D, Kakoulidou, M, Bridgeman, A, Reyes-Sandoval, A, Nicosia, A, Ljungberg, K, Hanke, T, Liljeström, P